{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:21:17Z","timestamp":1790338877888,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.ijantimicag.2012.06.022","type":"journal-article","created":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T08:30:53Z","timestamp":1344587453000},"page":"416-422","source":"Crossref","is-referenced-by-count":89,"title":["Quantification of seven \u03b2-lactam antibiotics and two \u03b2-lactamase inhibitors in human plasma using a validated UPLC-MS\/MS method"],"prefix":"10.1016","volume":"40","author":[{"given":"Mieke","family":"Carlier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Stove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Van de Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"De Waele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain G.","family":"Verstraete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0005","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0010","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2796.1998.00379.x","article-title":"The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection","volume":"244","author":"Leibovici","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1086\/514622","article-title":"The pharmacodynamics of \u03b2-lactams","volume":"27","author":"Turnidge","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0020","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/CCM.0b013e3181961bff","article-title":"Pharmacokinetic issues for antibiotics in the critically ill patient","volume":"37","author":"Roberts","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0025","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijantimicag.2010.06.008","article-title":"Therapeutic drug monitoring of \u03b2-lactams in critically ill patients: proof of concept","volume":"36","author":"Roberts","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0030","doi-asserted-by":"crossref","first-page":"R126","DOI":"10.1186\/cc9091","article-title":"Insufficient \u03b2-lactam concentrations in the early phase of severe sepsis and septic shock","volume":"14","author":"Taccone","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0035","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ijantimicag.2010.01.018","article-title":"Daily serum piperacillin monitoring is advisable in critically ill patients","volume":"35","author":"Blondiaux","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2125.2011.04080.x","article-title":"Therapeutic drug monitoring of antimicrobials","volume":"73","author":"Roberts","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0045","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/jms.1106","article-title":"Determination of clavulanic acid in calf plasma by liquid chromatography tandem mass spectrometry","volume":"41","author":"Reyns","year":"2006","journal-title":"J Mass Spectrom"},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0050","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC\u2013MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal Chem"},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1570-0232(02)00244-1","article-title":"Linear regression for calibration lines revisited: weighting schemes for bioanalytical methods","volume":"774","author":"Almeida","year":"2002","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0060","series-title":"Validation of analytical methods: methodology ICH Q2 B","author":"International Conference on Harmonization (ICH)","year":"1996"},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0065","unstructured":"European Medicines Agency (EMEA). Guideline on bioanalytical method validation. EMEA; 2011. EMEA\/CHMP\/EWP\/192217\/2009. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2011\/08\/WC500109686.pdf [accessed 30.03.12]."},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0070","series-title":"Application of LC\u2013MS in toxicology","article-title":"Method validation using LC\u2013MS","author":"Peters","year":"2006"},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0075","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/dta.218","article-title":"On the use of Kinetex\u2122-C18 core-shell 2.6\u03bcm stationary phase to the multiclass determination of antibiotics","volume":"3","author":"Samanidou","year":"2011","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0080","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jchromb.2011.03.001","article-title":"Simultaneous determination of eight \u03b2-lactam antibiotics in human serum by liquid chromatography\u2013tandem mass spectrometry","volume":"879","author":"Ohmori","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0085","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jchromb.2011.03.038","article-title":"A liquid chromatography assay for a quantification of doripenem, ertapenem, imipenem, meropenem concentrations in human plasma: application to a clinical pharmacokinetic study","volume":"879","author":"Dailly","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0090","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.jchromb.2010.05.027","article-title":"Analysis of 12 \u03b2-lactam antibiotics in human plasma by HPLC with ultraviolet detection","volume":"878","author":"McWhinney","year":"2010","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0095","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1002\/jssc.200600081","article-title":"Development of a validated HPLC method for the determination of four penicillin antibiotics in pharmaceuticals and human biological fluids","volume":"29","author":"Samanidou","year":"2006","journal-title":"J Sep Sci"},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0100","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cclet.2010.09.035","article-title":"Simultaneous determination of 14 \u03b2-lactam antibiotics in cosmetic products by liquid chromatography tandem mass spectrometry method","volume":"22","author":"Wu","year":"2011","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0105","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1128\/AAC.00533-11","article-title":"Simultaneous determination of 12 \u03b2-lactam antibiotics in human plasma by high-performance liquid chromatography with UV detection: application to therapeutic drug monitoring","volume":"55","author":"Verdier","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jchromb.2004.09.018","article-title":"Simultaneous determination of amoxicillin and clavulanic acid in human plasma by HPLC-ESI mass spectrometry","volume":"813","author":"Yoon","year":"2004","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jchromb.2008.01.037","article-title":"Simultaneous determination of five \u03b2-lactam antibiotics (cefepim, ceftazidim, cefuroxim, meropenem and piperacillin) in human plasma by high-performance liquid chromatography with ultraviolet detection","volume":"864","author":"Denooz","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.ijantimicag.2012.06.022_bib0120","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). Antimicrobial wild type distributions of microorganisms. EUCAST; 2012. http:\/\/mic.eucast.org\/Eucast2\/SearchController\/search.jsp?action=init [accessed 30.03.12]."}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912002774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857912002774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T10:31:26Z","timestamp":1542796286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857912002774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0924857912002774"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.06.022","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}